P&T Committee Meeting Oct. 20

The committee that advises the California Division of Workers’ Compensation on evidence-based updates to the prescription drug formulary will hear updates on COVID-19 vaccines and topical analgesics during an Oct. 20 meeting. Members of the Pharmacy and Therapeutics Committee will also discuss the limits on special fill and perioperative prescriptions. The formulary designates which drugs are exempt from utilization review and which require prior authorization. Some so-called “non-exempt” drugs have a “special fill” exception exempting them from prospective UR ...